Waters Announces Agenda for Applications of Time of Flight Mass Spectrometry Conference 06 Sep 2010: Waters Corporation and the University of California at Los Angeles (UCLA) will bring together some of the world's leading life science researchers and practitioners of mass spectrometry (MS) at a conference next month to discuss the ways they are applying time-of-flight mass spectrometry to complex biomolecule research and analysis. Waters
Recent articles:
New Te-Care™ Service Contracts for Detection Instruments 27 Aug 2010: Tecan has recently expanded its range of Te-Care™ Service Contracts with two new options designed specifically for users of Tecan detection instruments. Te-Care Check and Te-Care Depot Repair help to reduce instrument downtime and to ensure reliability of results. Tecan
New Diagnostic Test Helping in the Fight Against Ovarian Cancer 20 Aug 2010: A new test for ovarian cancer was demonstrated to be 99% to 100% accurate over 100 patient samples by Researchers at Georgia Institute of Technology. This new diagnostic technique is able to test a single drop of blood serum using JEOL's AccuTOF™-DART® mass spectrometer. JEOL USA
Application Data from Recent Oil Spill to Help Determine the Environmental Impact 13 Aug 2010: LECO has released a new application note highlighting the analysis of two petroleum samples obtained from the recent oil spill in the Gulf of Mexico. Using a Pegasus® 4D GCxGC-TOFMS with GERSTEL autosampler and ChromaTOF® software, the analyst was able to resolve and identify an unprecedented number of individual components in a single analysis for the ultimate in high throughput. LECO Corp.
Analysis of Drug Facilitated Sexual Assault (DFSA) Drugs by Gas Chromatography-Time-of-Flight Mass Spectrometry 29 Jun 2010: This poster displays the ability of GC-TOFMS to effectively screen case-study urine samples for the presence of potential DFSA drugs. The use of mass spectral deconvolution algorithms can increase sample throughput by reducing the need for total chromatographic resolution which allows shorter run times. Of the 24 samples analyzed, 16 contained drugs that would be considered potential DFSA drugs. LECO Corp.